Kristen M Kokkonen-Simon

Marked disparity of microRNA modulation by cGMP-selective PDE5 versus PDE9 inhibitors in heart disease.

Dong Ik Lee, Marc K. Halushka, David A. Kass, 2018, JCI insight.

Prevention of PKG-1&agr; Oxidation Suppresses Antihypertrophic/Antifibrotic Effects From PDE5 Inhibition but not sGC Stimulation

D. Kass, K. Tsujita, Grace E. Kim, 2018, Circulation. Heart failure.

Histone lysine dimethyl-demethylase KDM3A controls pathological cardiac hypertrophy and fibrosis

D. Kass, E. Olson, L. Liao, 2018, Nature Communications.

Right Ventricular Myofilament Functional Differences in Humans With Systemic Sclerosis–Associated Versus Idiopathic Pulmonary Arterial Hypertension

Ami A. Shah, D. Kass, M. Halushka, 2018, Circulation.

PKG1α Cysteine-42 Redox State Controls mTORC1 Activation in Pathological Cardiac Hypertrophy

Dong I. Lee, D. Kass, D. Bedja, 2020, Circulation research.